IGF-I activates the mouse type IIb myosin heavy chain gene

American Journal of Physiology - Cell Physiology

Volumn 297, Issue 4, 2009, Pages

  Shanely, R Andrew ^a,d   Zwetsloot, Kevin A ^a   Childs, Thomas E ^a   Lees, Simon J ^a   Tsika, Richard W ^a,b   Booth, Frank W ^a,b,c  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d APPALACHIAN STATE UNIVERSITY   (United States)

Author keywords

catenin; C2c12 myocytes; Insulin like growth factor I

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM CHLORIDE; MESSENGER RNA; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN IIB; NUCLEAR PROTEIN; SOMATOMEDIN C; T CELL FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; GENE ACTIVATION; GENE INDUCTION; GENETIC TRANSCRIPTION; MOUSE; MUSCLE MASS; MYOTUBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANDROSTADIENES; ANIMALS; BETA CATENIN; CELL DIFFERENTIATION; CELLS, CULTURED; CHROMONES; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; INSULIN-LIKE GROWTH FACTOR I; LITHIUM CHLORIDE; MICE; MORPHOLINES; MUSCLE FIBERS, SKELETAL; MUTATION; MYOSIN HEAVY CHAINS; PHOSPHATIDYLINOSITOL 3-KINASES; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 70349929457     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00169.2009     Document Type: Article

References (35)

1. Adams GR, McCue SA. Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. J Appl Physiol 84: 1716-1722, 1998.
2. Baldwin KM, Haddad F. Effects of different activity and inactivity paradigms on myosin heavy chain gene expression in striated muscle. J Appl Physiol 90: 345-357, 2001. (Pubitemid 32038537)
3. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA 95: 15603-15607, 1998. (Pubitemid 29018746)
4. Caiozzo VJ, Haddad F, Baker MJ, Baldwin KM. Influence of mechanical loading on myosin heavy-chain protein and mRNA isoform expression. J Appl Physiol 80: 1503-1512, 1996. (Pubitemid 26143897)
5. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21: 2933-2942, 2005. (Pubitemid 40916416)
6. Cox RD, Buckingham ME. Actin and myosin genes are transcriptionally regulated during mouse skeletal muscle development. Dev Biol 149: 228-234, 1992.
7. Cox RD, Weydert A, Barlow D, Buckingham ME. Three linked myosin heavy chain genes clustered within 370 kb of each other show independent transcriptional and post-transcriptional regulation during differentiation of a mouse muscle cell line. Dev Biol 143: 36-43, 1991. (Pubitemid 121004203)
8. Cross DA, Alessi DR, Vandenheede JR, McDowell HE, Hundal HS, Cohen P. The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem J 303: 21-26, 1994. (Pubitemid 24302893)
9. Delp MD, Duan C. Composition and size of type I, IIA, IID/X, and IIB fibers and citrate synthase activity of rat muscle. J Appl Physiol 80: 261-270, 1996. (Pubitemid 26034871)
10. Flint PW, Nakagawa H, Shiotani A, Coleman ME, O'Malley BW Jr. Effects of insulin-like growth factor-1 gene transfer on myosin heavy chains in denervated rat laryngeal muscle. Laryngoscope 114: 368-371, 2004. (Pubitemid 38182640)
11. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653: 1-24, 2003. (Pubitemid 36627817)
12. Glass DJ. Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol 37: 1974-1984, 2005.
13. Haddad F, Qin AX, Zeng M, McCue SA, Baldwin KM. Interaction of hyperthyroidism and hindlimb suspension on skeletal myosin heavy chain expression. J Appl Physiol 85: 2227-2236, 1998. (Pubitemid 28558080)
14. Hoppler S, Kavanagh CL. Wnt signalling: variety at the core. J Cell Sci 120: 385-393, 2007.
15. Huey KA, Roy RR, Baldwin KM, Edgerton VR. Temporal effects of inactivity on myosin heavy chain gene expression in rat slow muscle. Muscle Nerve 24: 517-526, 2001. (Pubitemid 32246788)
16. Karasseva N, Tsika G, Ji J, Zhang A, Mao X, Tsika R. Transcription enhancer factor 1 binds multiple muscle MEF2 and A/T-rich elements during fast-to-slow skeletal muscle fiber type transitions. Mol Cell Biol 23: 5143-5164, 2003. (Pubitemid 36950871)
17. Karolchik D, Baertsch R, Diekhans M, Furey TS, Hinrichs A, Lu YT, Roskin KM, Schwartz M, Sugnet CW, Thomas DJ, Weber RJ, Haussler D, Kent WJ. The UCSC Genome Browser Database. Nucleic Acids Res 31: 51-54, 2003.
18. Larkin SB, Ordahl CP. Multiple layers of control in transcriptional regulation by MCAT elements and the TEF-1 protein family. In: Heart Development, edited by Harvey RP and Rosenthal N. San Diego, CA: Academic, 1999, p. 307-329.
19. Machida S, Booth FW. Increased nuclear proteins in muscle satellite cells in aged animals as compared to young growing animals. Exp Gerontol 39: 1521-1525, 2004. (Pubitemid 39410552)
20. Musaro A, McCullagh K, Paul A, Houghton L, Dobrowolny G, Molinaro M, Barton ER, Sweeney HL, Rosenthal N. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 27: 195-200, 2001. (Pubitemid 32157448)
21. Rochat A, Fernandez A, Vandromme M, Moles JP, Bouschet T, Carnac G, Lamb NJ. Insulin and wnt1 pathways cooperate to induce reserve cell activation in differentiation and myotube hypertrophy. Mol Biol Cell 15: 4544-4555, 2004. (Pubitemid 39299103)
22. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 3: 1009-1013, 2001. (Pubitemid 34428746)
23. Schakman O, Kalista S, Bertrand L, Lause P, Verniers J, Ketelslegers JM, Thissen JP. Role of Akt/GSK-3beta/beta-catenin transduction pathway in the muscle anti-atrophy action of insulin-like growth factor (IGF)-I in glucocorticoid-treated rats. Endocrinology 149: 3900-3908, 2008.
24. Schiaffino S, Reggiani C. Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol Rev 76: 371-423, 1996. (Pubitemid 26163713)
25. 2+- dependent calcineurin signalling pathway. Nature 400: 576-581, 1999.
26. Stambolic V, Woodgett JR. Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem J 303: 701-704, 1994. (Pubitemid 24325998)
27. Sun J, Jin T. Both Wnt and mTOR signaling pathways are involved in insulin-stimulated proto-oncogene expression in intestinal cells. Cell Signal 20: 219-229, 2008. (Pubitemid 350138383)
28. Swoap SJ. In vivo analysis of the myosin heavy chain IIB promoter region. Am J Physiol Cell Physiol 274: C681-C687, 1998. (Pubitemid 28155608)
29. Takeda S, North DL, Lakich MM, Russell SD, Whalen RG. A possible regulatory role for conserved promoter motifs in an adult-specific muscle myosin gene from mouse. J Biol Chem 267: 16957-16967, 1992.
30. Tomczak KK, Marinescu VD, Ramoni MF, Sanoudou D, Montanaro F, Han M, Kunkel LM, Kohane IS, Beggs AH. Expression profiling and identification of novel genes involved in myogenic differentiation. FASEB J 18: 403-405, 2004.
31. Tsika RW, McCarthy J, Karasseva N, Ou Y, Tsika GL. Divergence in species and regulatory role of β-myosin heavy chain proximal promoter muscle-CAT elements. Am J Physiol Cell Physiol 283: C1761-C1775, 2002. (Pubitemid 35340609)
32. Van der Velden JLJ, Langen RC, Kelders MC, Wouters EF, Janssen-Heininger YM, Schols AM. Inhibition of glycogen synthase kinase-3β activity is sufficient to stimulate myogenic differentiation. Am J Physiol Cell Physiol 290: C453-C462, 2006.
33. Vyas DR, Spangenburg EE, Abraha TW, Childs TE, Booth FW. GSK-3β negatively regulates skeletal myotube hypertrophy. Am J Physiol Cell Physiol 283: C545-C551, 2002.
34. Wheeler MT, Snyder EC, Patterson MN, Swoap SJ. An E-box within the MHC IIB gene is bound by MyoD and is required for gene expression in fast muscle. Am J Physiol Cell Physiol 276: C1069-C1078, 1999.
35. Willert K, Jones KA. Wnt signaling: is the party in the nucleus? Genes Dev 20: 1394-1404, 2006. (Pubitemid 43830647)